Detalhe da pesquisa
1.
Ejaculatory Function Following Stereotactic Body Radiation Therapy for Prostate Cancer.
J Sex Med
; 19(5): 771-780, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305936
2.
Prognostic utility of biopsy-based PTEN and ERG status on biochemical progression and overall survival after SBRT for localized prostate cancer.
Front Oncol
; 14: 1381134, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38585005
3.
Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer.
Cureus
; 16(3): e55729, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38586683
4.
Early biochemical outcomes following neoadjuvant/adjuvant relugolix with stereotactic body radiation therapy for intermediate to high risk prostate cancer.
Front Oncol
; 13: 1289249, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916156
5.
Intensity modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: five-year outcomes.
Front Oncol
; 13: 1240939, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38074646
6.
Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer.
Acta Oncol
; 56(8): 1136-1138, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270015
7.
Evaluation of Four Fully Integrated Molecular Assays for the Detection of Respiratory Viruses during the Co-Circulation of SARS-CoV-2, Influenza and RSV.
J Clin Med
; 11(14)2022 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887705
8.
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
Front Oncol
; 12: 852844, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35402242
9.
Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer.
Front Oncol
; 11: 796496, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35127506
10.
Impact of Age on Patient-Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer.
Cureus
; 13(3): e13780, 2021 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33842156
11.
Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy.
Front Oncol
; 11: 722852, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34604059
12.
Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate Cancer.
Front Oncol
; 10: 616286, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718117
13.
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer in Men With a High Baseline International Prostate Symptom Score (IPSS ≥ 15).
Front Oncol
; 10: 1060, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32719744
14.
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate Cancer.
Front Oncol
; 10: 551491, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33251131
15.
Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP).
Front Oncol
; 10: 555, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32432033
16.
The Mechanisms of PML-Nuclear Body Formation.
Mol Cell
; 24(5): 805, 2006 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29654784
17.
Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT).
Front Oncol
; 9: 1528, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32039015
18.
Utilization of Patient-Reported Outcomes to Guide Symptom Management during Stereotactic Body Radiation Therapy for Clinically Localized Prostate Cancer.
Front Oncol
; 7: 227, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29085804
19.
Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?
Front Oncol
; 7: 157, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28791252
20.
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on 3-Year Toxicity.
Front Oncol
; 7: 5, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28224113